Found: 75
Select item for more details and to access through your institution.
Expression pattern, genomic structure and evaluation of the human SLC30A4 gene as a candidate for acrodermatitis enteropathica.
- Published in:
- Human Genetics, 2001, v. 109, n. 2, p. 178, doi. 10.1007/s004390100539
- By:
- Publication type:
- Article
Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: Relation to morphology, cell proliferation and expression of breast cancer-related genes.
- Published in:
- International Journal of Cancer, 2000, v. 89, n. 5, p. 403, doi. 10.1002/1097-0215(20000920)89:5<403::AID-IJC2>3.0.CO;2-3
- By:
- Publication type:
- Article
Genetic alterations in early-onset invasive breast carcinomas: Correlation of c- erbB-2 amplification detected by fluorescence In situ hybridization with p53 accumulation and tumor phenotype.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 5, p. 511, doi. 10.1002/(SICI)1097-0215(19991022)84:5<511::AID-IJC11>3.0.CO;2-5
- By:
- Publication type:
- Article
Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 274, doi. 10.1111/ejh.13435
- By:
- Publication type:
- Article
c‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 1, p. 35, doi. 10.1111/ejh.13405
- By:
- Publication type:
- Article
Myeloma Molecular Pathways and Cytogenetics.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S6
- By:
- Publication type:
- Article
The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
- Published in:
- BMC Genomics, 2013, v. 14, n. 1, p. 672, doi. 10.1186/1471-2164-14-672
- By:
- Publication type:
- Article
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
- Published in:
- Nature Communications, 2014, v. 5, n. 1, p. 2997, doi. 10.1038/ncomms3997
- By:
- Publication type:
- Article
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2019, v. 57, n. 9, p. 1397, doi. 10.1515/cclm-2018-1369
- By:
- Publication type:
- Article
Imprinting of Mesenchymal Stromal Cell Transcriptome Persists even after Treatment in Patients with Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3854, doi. 10.3390/ijms21113854
- By:
- Publication type:
- Article
The dChip survival analysis module for microarray data.
- Published in:
- BMC Bioinformatics, 2011, v. 12, n. 1, p. 72, doi. 10.1186/1471-2105-12-72
- By:
- Publication type:
- Article
Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.
- Published in:
- Genes, Chromosomes & Cancer, 2000, v. 29, n. 4, p. 350, doi. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1041>3.0.CO;2-W
- By:
- Publication type:
- Article
Amplification of the 11q23 region in acute myeloid leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 26, n. 2, p. 166, doi. 10.1002/(SICI)1098-2264(199910)26:2<166::AID-GCC9>3.0.CO;2-P
- By:
- Publication type:
- Article
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
- Published in:
- Genes, Chromosomes & Cancer, 1999, v. 24, n. 1, p. 9, doi. 10.1002/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO;2-K
- By:
- Publication type:
- Article
Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 1998, v. 23, n. 2, p. 175, doi. 10.1002/(SICI)1098-2264(199810)23:2<175::AID-GCC11>3.0.CO;2-N
- By:
- Publication type:
- Article
Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas.
- Published in:
- Genes, Chromosomes & Cancer, 1996, v. 17, n. 3, p. 156, doi. 10.1002/(SICI)1098-2264(199611)17:3<156::AID-GCC3>3.0.CO;2-3
- By:
- Publication type:
- Article
OAB-043: Progression and probability of progression are driven by different genomic features in precursor conditions in myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S28, doi. 10.1016/S2152-2650(21)02117-0
- By:
- Publication type:
- Article
OAB-022: Monoallelic deletion of BCMA locus is a frequent feature in MM and is associated with increased genomic loss.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S14, doi. 10.1016/S2152-2650(21)02096-6
- By:
- Publication type:
- Article
OAB-008: Identification of high-risk Multiple Myeloma with a plasma cell Leukemia-like transcriptomic profile.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02082-6
- By:
- Publication type:
- Article
Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Weekly 20/56mg/m2 Carfilzomib, Lenalidomide and Dexamethasone until progression in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.426
- By:
- Publication type:
- Article
Pomalidomide 3rd line versus 4th line for in Early Relapsed Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e258, doi. 10.1016/j.clml.2019.09.427
- By:
- Publication type:
- Article
Maintenance with Weekly Carfilzomib in Elderly newly Diagnosed Multiple Myeloma (IFM 2012-03).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e44, doi. 10.1016/j.clml.2019.09.066
- By:
- Publication type:
- Article
A First In-Depth Analysis of Alternate Splicing Landscape in Multiple Myeloma with Significant Potential Biological and Clinical Implications.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e13, doi. 10.1016/j.clml.2019.09.018
- By:
- Publication type:
- Article
Recurrent somatic Alterations in the Non-Coding Genome Alter Gene Expression Levels and Correlate With Clinical Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e12, doi. 10.1016/j.clml.2019.09.017
- By:
- Publication type:
- Article
Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e3, doi. 10.1016/j.clml.2019.09.005
- By:
- Publication type:
- Article
Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Multiple Myeloma Genome Project: Development of a Molecular Segmentation Strategy for Risk Stratification of Multiple Myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e26, doi. 10.1016/j.clml.2017.03.044
- By:
- Publication type:
- Article
Non-overlapping Promoter and Super-enhancer Driven Processes Support Myeloma Cell Growth and Survival via Distinct Regulatory Axes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e1, doi. 10.1016/j.clml.2017.03.002
- By:
- Publication type:
- Article
Polyclonal Immunoglobulin Recovery is Enhanced After Autologous Stem Cell Transplant and Associates with Improved Clinical Outcomes in Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e103, doi. 10.1016/j.clml.2017.03.187
- By:
- Publication type:
- Article
Response Assignment Using Hevylite Correlates With Clinical Outcome in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e44, doi. 10.1016/j.clml.2017.03.079
- By:
- Publication type:
- Article
Impfempfehlungen beim Multiplen Myelom: ein Konsensbericht des European Myeloma Network.
- Published in:
- Kompass Onkologie, 2022, v. 9, n. 1, p. 3, doi. 10.1159/000522451
- By:
- Publication type:
- Article
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00759-6
- By:
- Publication type:
- Article
Genetically determined telomere length and multiple myeloma risk and outcome.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 4, p. 1, doi. 10.1038/s41408-021-00462-y
- By:
- Publication type:
- Article
Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple Myeloma.
- Published in:
- Frontiers in Physiology, 2017, v. 8, p. 1, doi. 10.3389/fphys.2017.00149
- By:
- Publication type:
- Article
Immunophénotypage du myélome multiple : validation de la méthode.
- Published in:
- Annales de Biologie Clinique, 2019, v. 77, n. 2, p. 197, doi. 10.1684/abc.2019.1426
- By:
- Publication type:
- Article
Persistence of CD33 expression at relapse in CD33<sup>+</sup> acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
- Published in:
- 2008
- By:
- Publication type:
- Letter
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 1, p. 142, doi. 10.1046/j.0007-1048.2001.3205.x
- By:
- Publication type:
- Article
Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13.
- Published in:
- British Journal of Haematology, 2000, v. 111, n. 4, p. 1116, doi. 10.1046/j.1365-2141.2000.02488.x
- By:
- Publication type:
- Article
IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated V<sub>H</sub> genes undergoing Ig isotype-switching frequently associated with trisomy 12.
- Published in:
- British Journal of Haematology, 2000, v. 109, n. 1, p. 71, doi. 10.1046/j.1365-2141.2000.01971.x
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 257, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Functional Comparison between Healthy and Multiple Myeloma Adipose Stromal Cells.
- Published in:
- Stem Cells International, 2020, p. 1, doi. 10.1155/2020/4173578
- By:
- Publication type:
- Article
Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059127
- By:
- Publication type:
- Article
Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058809
- By:
- Publication type:
- Article